Delivery Order SPE2DB22D3011-SPE2DB25FQ2XT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,938.25 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 24-26 mg tablets (60-count supply) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets (60-count) valued at $2,202.57. This is a firm fixed-price, non-set-aside contract with performance to be completed by September 16, 2025, and fulfillment occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,207.60 to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 24-26 mg tablets (60-count supply). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 11, 2025, and performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $18,186.68 to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 24-26 mg tablets (60 count) on September 9, 2025, with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $2,160.00 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 97-103 mg tablets (60-count units) on August 7, 2025, with completion expected by August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 180 tablets of Sacubitril-Valsartan 97-103 mg, with a contract ceiling value of $1,066.02. This is a firm fixed-price delivery order with an award date of September 5, 2025, and ultimate completion date of September 8, 2025. The contract was competitively awarded without set-aside designation, and performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,589.05 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets (180-count). The contract, which carries a firm fixed price structure with no set-aside designation, is scheduled for completion by September 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $44,508.93 delivery order to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 49-51 mg tablets (180-count supply) under a firm fixed price contract structure. The award was issued on September 5, 2025, with an ultimate completion date of September 8, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate...
- The Defense Logistics Agency awarded a $2,703.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets (60-count). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 5, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of AmerisourceBergen's ongoing pharmaceutical supply operations...
- The Defense Logistics Agency awarded a delivery order valued at $4,597.63 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 49-51 mg tablets (60-count supply) on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2XTDelivery Order
The Defense Logistics Agency awarded a $2,868.48 delivery order to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 24-26 mg tablets (60-count supply) on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child delivery order under its larger relationship with the federal government. This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and related military healthcare systems. AmerisourceBergen Drug Corp operates under a significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the overarching vehicle enabling the company to supply pharmaceuticals and medical commodities globally to support military healthcare programs. The contractor's federal procurement history demonstrates consistent capability in competitively awarded medical supply contracts across multiple therapeutic domains, positioning it as a critical vendor for federal medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/24/25 |